Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

The Addition of Brentuximab Vedotin to ESHAP Significantly Increases the Rate of Metabolic Complete Remissions Vs Chemotherapy Alone. in Patients with Relapsed/Refractory Classical Hodgkin's Lymphoma. Final Results of a Phase IIb Prospective Randomized Clinical Trial (BRESELIBET)

Blood (2024) 144 (Supplement 1): 3049.

https://doi.org/10.1182/blood-2024-211527

Published: 2024

Journal Articles

Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)

Blood (2024) 144 (Supplement 1): 4390.

https://doi.org/10.1182/blood-2024-197940

Published: 2024

Journal Articles

Clinical and Biological Impact of TP53 Alterations in Del(11q) Chronic Lymphocytic Leukemia

Claudia Pérez Carretero, MSc, BSc, Miguel Quijada Álamo, MSc, Maria Hernandez-Sanchez, PhD, Ana E. Rodriguez, PhD, Ana B Herrero, PhD, Jesus M Hernández-Sánchez, PhD, Marta Martín Izquierdo, MSc, Teresa González, PhD, Sandra Santos-Mínguez, Cristina Miguel-García, Araceli Rubio-Martínez, Alfonso García de Coca, MD PhD, Julio Dávila, Jose-Angel Hernandez, MD PhD, Rocio Benito, PhD, José Luis Ordóñez, PhD, Jesus Maria Hernández-Rivas, MD PhD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-141015

Published: 2020

Journal Articles

Chronic Lymphocytic Leukemia Patients with IGH Rearrangements Are Characterized By a Distinct Genetic Landscape with Prognostic Implications

Blood (2018) 132 (Supplement 1): 3129.

https://doi.org/10.1182/blood-2018-99-115959

Published: 2018

Journal Articles

Serum free Light Chains Profile as Early Biomarker with Predictive Value after autologous Transplant in Multiple Myeloma

Valle Recasens, Rebeca Rubio-Escuin, Araceli Rubio-Martinez, Transito Pascual, Natividad Lopez, Mjose Sanjuan, Pilar Giraldo, MD, PhD

Blood (2008) 112 (11): 5142.

https://doi.org/10.1182/blood.V112.11.5142.5142

Published: 2008

Journal Articles

Quality Analysis of a Multidisciplinary Program Project in Radioimmunotherapy.

Valle Recasens, MD, Araceli Rubio-Martinez, MD PhD, Maria J. Agustin, MD, Carlos Lopez, Teresa Galego, Maria J. Ciria, Rebeca Rubio-Escuin, MD, Teresa Baringo, MD PhD, Pilar Giraldo, MD, PhD

Blood (2007) 110 (11): 5152.

https://doi.org/10.1182/blood.V110.11.5152.5152

Published: 2007

Journal Articles

Mycosis Fungoide: Immunochemistry Analysis of Lymphoid and Microenvironment Cells by Macrotissue Array.

Celia del Agua, MD, Araceli Rubio-Martinez, MD PhD, Francesc Filipo, MD PhD, Miguel A. Piris, MD PhD, Pilar Giraldo, MD, PhD

Blood (2007) 110 (11): 4400.

https://doi.org/10.1182/blood.V110.11.4400.4400

Published: 2007

Journal Articles

Expression Profiles in Chronic Lymphoid Leukemia by Hematochip Analysis.

Patricia Alvarez, MD PhD, Virginia Leon, MD, Gonzalo Caballero, MD, Araceli Rubio-Martinez, MD PhD, Miguel Pocovi, MD PhD, Pilar Giraldo, MD PhD

Blood (2007) 110 (11): 4676.

https://doi.org/10.1182/blood.V110.11.4676.4676

Published: 2007

Journal Articles

Late Onset Neutropenia like a Complication of Treatment with Anti-CD20.

Araceli Rubio-Martinez, MD, PhD, Valle Recasens, MD, Ana Godoy, MD, Noelia Padron, MD, Pilar Giraldo, MD, PhD

Blood (2006) 108 (11): 4701.

https://doi.org/10.1182/blood.V108.11.4701.4701

Published: 2006

Journal Articles

Maintenance Treatment with Rituximab in Follicular NHL.

Araceli Rubio-Martinez, MD, PhD, Valle Recasens, MD, Pilar Giraldo, MD, PhD

Blood (2006) 108 (11): 4702.

https://doi.org/10.1182/blood.V108.11.4702.4702

Published: 2006

Journal Articles

CHOP Every 14 Days in Naïve Patients with Diffuse B-Large Cell Lymphoma.

Araceli Rubio-Martinez, MD, PhD, Luis Palomera, MD, Nicolas Gonzalez, MDPhD, Jose A. Domingo, MDPhD, Carlos Arguinano, MDPhD, Fernando Puente, MDPhD, Matilde Perella, MD, Jose A. Angos, MD, Ignacio Sancho, MD, Pilar Herrera, MD, Valle Recasens, MD, Pilar Giraldo, MDPhD

Blood (2006) 108 (11): 4668.

https://doi.org/10.1182/blood.V108.11.4668.4668

Published: 2006

Journal Articles

Response to Bortezomib in Combination after Relapse o Non-Response to First Treatment with Bortezomib Alone in Myeloma Multiple Patients.

Araceli Rubio-Martinez, MD, PhD, Valle Recasens, MD, Pilar Delgado, MDPhD, Juan Carlos Garcia-Zueco, MDPhD, Daniel Rubio-Felix, MDPhD, Pilar Giraldo, MDPhD

Blood (2006) 108 (11): 5094.

https://doi.org/10.1182/blood.V108.11.5094.5094

Published: 2006

Journal Articles

Genetic Aberrations and Response to Fludarabine as First Line Treatment in a Serie of B-CLL Patients.

Pilar Giraldo, MD, PhD, Araceli Rubio-Martinez, MDPhD, Valle Recasens, MD, Mikel Valganon, MD, Paz Latre, MD, Daniel Rubio-Felix, MDPhD, Maria J. Calasanz, MDPhD, Maria D. Odero, MDPhD

Blood (2005) 106 (11): 2131.

https://doi.org/10.1182/blood.V106.11.2131.2131

Published: 2005

Journal Articles

CML and Imatinib Mesylate: Response Related to Karyotype.

Araceli Rubio-Martinez, MD, PhD, Valle Recasens, MD, Maria D. Odero, MDPhD, Daniel Rubio-Felix, MDPhD, Maria J. Calasanz, MDPhD, Pilar Mayayo, MD, Manuel Giralt, MDPhD, Pilar Giraldo, MDPhD

Blood (2005) 106 (11): 4866.

https://doi.org/10.1182/blood.V106.11.4866.4866

Published: 2005

Journal Articles

Evaluation of Response to Anti-CD20 (Rituximab) Trial in Relapsed Follicular Lymphoma after Six Years in Follow-Up.

Araceli Rubio-Martinez, MD, PhD, Luis Palomera, MD, PhD, Valle Recasens, MD, Maria J. Najera, MD, Matilde Perella, MD, Fernando Puente, MD, Luis Perdiguer, MD, Daniel Rubio-Felix, MD, PhD, Pilar Mayayao, MD, Pilar Giraldo, MD, PhD

Blood (2005) 106 (11): 4784.

https://doi.org/10.1182/blood.V106.11.4784.4784

Published: 2005

Journal Articles

Preliminary Results of Therapy with AM3 in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Valle Recasens, MD, Araceli Rubio-Martinez, MDPhD, Pilar Alfonso, MDPhD, Ignacio De Blas, MDPhD, Daniel Rubio-Felix, MDPhD, Pilar Delgado, MDPhD, Juan Carlos Garcia-Zueco, MDPhD, Pilar Giraldo, MDPhD

Blood (2005) 106 (11): 5370.

https://doi.org/10.1182/blood.V106.11.5370.5370

Published: 2005

Journal Articles

Economical Analysis of Implementation of External Quality Controls in a General Hospital Hematology Laboratory.

Valle Recasens, MD, Araceli Rubio-Martinez, MDPhD, Pilar Giraldo, MDPhD, Jose F. Lucia, MDPhD, Manuela Dobon, MDPhD, Maria A. Montanes, MD, Eduardo Bustamante, MDPhD, Juan R. Garcia-Mata, MDPhD, Juan R. Portillo, MDPhD, Manuel Giralt, MDPhD

Blood (2005) 106 (11): 5590.

https://doi.org/10.1182/blood.V106.11.5590.5590

Published: 2005

Journal Articles

Langerhans Cells Histiocytosis: Description of 6 Cases.

Araceli Rubio, MDPhD, Valle Recasens, MD, Manuela Dobon, MD, Carlos Salvador, MD, Manuel Giralt, MDPhD, Pilar Giraldo, MDPhD

Blood (2004) 104 (11): 3805.

https://doi.org/10.1182/blood.V104.11.3805.3805

Published: 2004

Journal Articles

Recurrent Histiocytosis Evolving to Myelodendritic Leukemia.

Araceli Rubio, MDPhD, Valle Recasens, MD, Carmen Perez-Barrachina, MD, Alberto Orfao, MDPhD, Pilar Giraldo, MDPhD

Blood (2004) 104 (11): 3831.

https://doi.org/10.1182/blood.V104.11.3831.3831

Published: 2004

Journal Articles

CML and Environmental Factors Related to Complex Karyotypes.

Valle Recasens, MD, Araceli Rubio-Martinez, MDPhD, Maria Odero, MDPhD, Maria Jose Calasanz, MDPhD, Luis Palomera, MD, Fernando Puente, MDPhD, Daniel Rubio-Felix, MDPhD, Pilar Giraldo, MDPhD

Blood (2004) 104 (11): 4654.

https://doi.org/10.1182/blood.V104.11.4654.4654

Published: 2004

NARROW

The Addition of Brentuximab Vedotin to ESHAP Significantly Increases the Rate of Metabolic Complete Remissions Vs Chemotherapy Alone. in Patients with Relapsed/Refractory Classical Hodgkin's Lymphoma. Final Results of a Phase IIb Prospective Randomized Clinical Trial (BRESELIBET)

Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study)

Clinical and Biological Impact of TP53 Alterations in Del(11q) Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia Patients with IGH Rearrangements Are Characterized By a Distinct Genetic Landscape with Prognostic Implications

Serum free Light Chains Profile as Early Biomarker with Predictive Value after autologous Transplant in Multiple Myeloma

Quality Analysis of a Multidisciplinary Program Project in Radioimmunotherapy.

Mycosis Fungoide: Immunochemistry Analysis of Lymphoid and Microenvironment Cells by Macrotissue Array.

Expression Profiles in Chronic Lymphoid Leukemia by Hematochip Analysis.

Late Onset Neutropenia like a Complication of Treatment with Anti-CD20.

Maintenance Treatment with Rituximab in Follicular NHL.

CHOP Every 14 Days in Naïve Patients with Diffuse B-Large Cell Lymphoma.

Response to Bortezomib in Combination after Relapse o Non-Response to First Treatment with Bortezomib Alone in Myeloma Multiple Patients.

Genetic Aberrations and Response to Fludarabine as First Line Treatment in a Serie of B-CLL Patients.

CML and Imatinib Mesylate: Response Related to Karyotype.

Evaluation of Response to Anti-CD20 (Rituximab) Trial in Relapsed Follicular Lymphoma after Six Years in Follow-Up.

Preliminary Results of Therapy with AM3 in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Economical Analysis of Implementation of External Quality Controls in a General Hospital Hematology Laboratory.

Langerhans Cells Histiocytosis: Description of 6 Cases.

Recurrent Histiocytosis Evolving to Myelodendritic Leukemia.

CML and Environmental Factors Related to Complex Karyotypes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only